Screener
/
SEC EDGAR
/CIK 0001520262
/10-K filed Feb 25, 2026, compared with Feb 12, 2025
/Numbers from the XBRL of the 10-Ks
Nasdaq
Health care · Pharmaceuticals
Alkermes plc. ALKS
Investor presentations
22 kept
8-K exhibits, EX-99
Latest presentation
Nov 3, 2026
Third Quarter 2026Financial Results & Business Update November 3, 2026 Exhibit 99.2 Forwar…
Presentations kept
22
oldest Nov 15, 2023
8-Ks read
36
with item 7.01, 2.02 or 8.01, since May 24, 2017
- 12023
- 72024
- 92025
- 52026
Every presentation
Newest first · linked to sec.gov
| Filed | What it is | |
|---|---|---|
| Nov 3, 2026 | Presentation Third Quarter 2026Financial Results & Business Update Novemb… | As filed · filing |
| Jul 28, 2026 | Presentation Second Quarter 2026Financial Results & Business Update July … | As filed · filing |
| May 5, 2026 | Presentation First Quarter 2026Financial Results & Business Update May 5,… | As filed · filing |
| Feb 25, 2026 | Presentation Fourth Quarter and Year-End 2025 Financial Results & Busines… | As filed · filing |
| Jan 12, 2026 | Presentation Alkermes 2026: Driving Profitable Growth in Neuroscience and… | As filed · filing |
| Nov 12, 2025 | Presentation Vibrance-2 Phase 2 Study of Alixorexton in Patients with Nar… | As filed · filing |
| Oct 28, 2025 | Presentation Third Quarter 2025Financial Results & Business Update Octobe… | As filed · filing |
| Oct 22, 2025 | Presentation Proposed Acquisition of Avadel Pharmaceuticals plc October 2… | As filed · filing |
| Sep 8, 2025 | Presentation Vibrance-1 Alixorexton Phase 2 Study in Patients with Narcol… | As filed · filing |
| Sep 8, 2025 | Presentation Table of Contents Important Information About This Document … | As filed · filing |
| Jul 29, 2025 | Presentation Second Quarter 2025Financial Results & Business Update July … | As filed · filing |
| May 1, 2025 | Presentation First Quarter 2025Financial Results & Business Update May 1,… | As filed · filing |
| Feb 12, 2025 | Presentation Fourth Quarter and Year-End 2024 Financial Results & Busines… | As filed · filing |
| Jan 13, 2025 | Presentation Alkermes 2025 Richard Pops Chief Executive Officer 43rd Annu… | As filed · filing |
| Dec 2, 2024 | Presentation Alkermes 2024: Profitable, Pure-play Neuroscience Company De… | As filed · filing |
| Oct 24, 2024 | Presentation Third Quarter 2024 Financial Results & Business Update Octob… | As filed · filing |
| Oct 9, 2024 | Presentation Alkermes Orexin Portfolio Strategy Review October 9, 2024 Ex… | As filed · filing |
| Jul 24, 2024 | Presentation Second Quarter 2024 Financial Results & Business Update July… | As filed · filing |
| May 1, 2024 | Presentation First Quarter 2024 Financial Results & Business Update May 1… | As filed · filing |
| Feb 15, 2024 | Presentation Fourth Quarter and Year-End 2023 Financial Results & Busines… | As filed · filing |
| Jan 8, 2024 | Presentation Alkermes 2024: Profitable, Pure-play Neuroscience Company Ri… | As filed · filing |
| Nov 15, 2023 | Presentation Alkermes Corporate Presentation November 2023 Exhibit 99.2 F… | As filed · filing |
Show the other 10 presentations
A presentation is an 8-K exhibit that SEC's index or the document's own title calls a presentation, investor update or earnings supplement. Decks a company shows only on its own website are not filed with SEC and are not here.
Sources
The exhibits of the company's 8-Ks (SEC EDGAR) that are slide decks. Each row links to the filing on sec.gov.
Also
Earnings releases: the text of each quarter's results release.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ALKS/export.csv") into a cell.